when mylan was trading at ridiculous low price mgt became extremely nervous. they adopted the poison pill because they knew true value of the company and they were in danger.
insiders control very little of the stock they are ripe for a a takeover could be pfizer.pfizer is not to happy about mylans generic version of procardia xl.lilly has close ties with mylan could happen soon.the poison pill will make sure shareholders are treated fairly. K2B1
mylan is headed for 15 to 16 k2b1.what the hell does that stand for anyways? they will get plenty of competition on zantac profit margins will erode.stock always goes down anyways. you can buy it alot cheater. besides its too dam expensive right now. you dont know what your talking about.
I've been seeing rumers being spread in this message column about all sorts of companies that might be targeting Mylan and at prices like $32 etc.
It is common knowledge that companies like Bayer and Hoechst have been looking at companies and Mylan might fit the bill for such a company.... not Pfizer or Merk. In any event, the insiders at Mylan picked up stock last year and set up the poison pill becasue they knew that they were developing a new stradegy that was going to make the company attractive. Earnings will most definitely climb from here on out and the stock is going to go up